general conditions of use
privacy statement
imprint
© 2007 Bayer HealthCare Pharmaceuticals

 


Physician Support
Video: Insertion and Removal Procedures for Once-Yearly Viadur
   
     
 

Select the video clip appropriate to your operating system and internet connection speed below.
Click here for additional technical information.

Copies of this video are available through your Bayer sales representative, or for more information, please contact Bayer Clinical Communications at 1-800-288-8371.

Table of Contents

Introduction

 

Windows Media Player:
High Speed Connection
Dial-up Connection

  Quicktime:
High Speed Connection
Dial-up Connection

Chapter 1: Sterile Kit*

  Windows Media Player:
High Speed Connection
Dial-up Connection
  Quicktime:
High Speed Connection

Dial-up Connection

Chapter 2: Insertion Procedure*

  Windows Media Player:
High Speed Connection

Dial-up Connection
  Quicktime:
High Speed Connection

Dial-up Connection

Chapter 3: Osmotic Technology

  Windows Media Player:
High Speed Connection

Dial-up Connection
  Quicktime:
High Speed Connection

Dial-up Connection

Chapter 4: Removal Procedure

  Windows Media Player:
High Speed Connection

Dial-up Connection
  Quicktime:
High Speed Connection

Dial-up Connection

Chapter 5: Summary

  Windows Media Player:
High Speed Connection

Dial-up Connection
  Quicktime:
High Speed Connection

Dial-up Connection

Chapter 6: Safety Considerations

  Windows Media Player:
High Speed Connection

Dial-up Connection
  Quicktime:
High Speed Connection

Dial-up Connection

Chapter 7: Conclusion

  Windows Media Player:
High Speed Connection

Dial-up Connection
  Quicktime:
High Speed Connection

Dial-up Connection

Package Insert Information

  Complete prescribing information is available in PDF format.
 

Download entire video ( 200 x 175 pixels )

 

Windows Users:
Right-click the link below
25 minutes / 28.8 modem

Windows Media Player

  Mac Users:
Control + click the link below
25 minutes / 28.8 modem

Quicktime
         
    *The configuration of the kit may vary slightly from the one depicted in this video.
         
 
Prescribing and Safety Information
 
Calendar of Events
 
Reimbursement Support
 

Physician FAQs

Important Safety Considerations
Viadur is contraindicated in patients with hypersensitivity to Gn-RH, Gn-RH agonist analogs, or any of the components in Viadur.

Viadur is contraindicated in women and pediatric patients and was not studied in women or children.

Viadur, like other LH-RH agonists, causes a transient increase in serum concentrations of testosterone during the first week of treatment. Patients may experience a worsening of symptoms or onset of new symptoms including bone pain, neuropathy, hematuria, or ureteral or bladder outlet obstruction, and spinal cord compression.

The most comment systemic side effects were hot flashes (67.9%), asthenia (7.6%), gynecomastia (6.9%), depression (5.3%), and sweating (5.3%). The most common local side effects were bruising (34.6%) and burning (5.6%).


Distributed and Marketed by:

Manufactured by:

Bayer HealthCare Pharmaceuticals
6 West Belt, Wayne, NJ 07470 USA

© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals. DUROS® is a registered trademark of ALZA Corporation.

The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.